Sofinnova Investments Strengthens Executive Team with Promotions of Maha Katabi, PhD, CFA and Sarah Bhagat, PhD MENLO PARK, Calif., March 31, 2020-- Sofinnova Investments, a clinical stage biopharmaceutical investment firm, announces the promotions of Maha Katabi, PhD, CFA to General Partner and Sarah Bhagat, PhD to Partner. Maha Katabi, PhD, CFA who joined Sofinnova in April 2019, has been essential to the firm’s executive team in addition to enhancing the team’s geographic investment coverage across North America and Europe. She is an experienced investor in biopharma companies, with more than two decades of venture capital and public equities investment experience.